The growing interest in effective weight management has led to considerable research into cutting-edge treatments. Recently , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor stimulator, has demonstrated positive results in patient trials, suggesting potential for significant weight loss . As a result